4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001193125-26-054568
Director sold 100,000 shares at an average $5.29 ($529,129)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Thomas Stephen Basil · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-12 | Sale : show line 1 in the form 10b5-1 | −90,000 | $5.23 | $470,988 | 214,657 | D |
| 2026-02-13 | Sale : show line 2 in the form 10b5-1 | −10,000 | $5.81 | $58,141 | 204,657 | D |
| Open-market sales · 100,000 sh · avg $5.29 · $529,129 | ||||||
Loading xslF345X05/ownership.xml…